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In this study, a simple and rapid ionmobility spectrometry (IMS)method has been described
for the determination of tramadol. The operating instrumental parameters that could in-
fluence IMS were investigated and optimized (temperature; injection: 220 and IMS cell:
190C, flow rate; carrier: 300 and drift: 600mL/minute, voltage; corona: 2300 and drift: 7000 V,
pulse width: 100 ms). Under optimum conditions, the calibration curves were linear within
two orders of magnitude with R2  0.998 for the determination of tramadol in human
plasma, saliva, serum, and urine samples. The limits of detection and the limits of quan-
titation were between 0.1 and 0.3 and 0.3 and 1 ng/mL, respectively. The relative standard
deviations were between 7.5 and 8.8%. The recovery results (90e103.9%) indicate that the
proposed method can be applied for tramadol analysis in different biological samples.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
Drug abuse is a patterned use of a substance (drug) in which
the user consumes the substance in amounts or withmethods
whichareharmful to themselves or others. This issuehasbeen
addressed in many countries [1,2]. Tramadol 2-[(dimethyla-
mino) methyl]-1-(3-methoxyphenyl) cyclohexanol (Fig. 1) is a
centrally acting analgesic drug used for treating moderate to
chronic pain. This drug, like morphine and other narcotics,
mayalso be abused [3,4]. Hence, thedeterminationof tramadol
in human biological samples is important because it can pro-
vide information about long-term abuse and is also helpful for
forensic purposes. Various methods have been reported for
tramadol determination such as high performance liquid
chromatography (HPLC) [5,6], gas chromatography (GC) [7],
capillary electrophoresis [8], spectrophotometry [9], andistry, Yazd Branch, Islam
. Sheibani).
ministration, Taiwan. Publelectrochemistry [10,11]. However, it is necessary to develop a
rapid, simple, and sensitive method for the determination of
tramadol in biological samples.
Ion mobility spectrometry (IMS) has been used for over 40
years since 1970. It is an analytical method for determination
and characterization of trace substances present in different
samples. In forensic sciences, IMS is used as a detection tool to
prove the presence of latent traces of illicit drugs or explosives
on surfaces of suspicious or confiscated material of evidence.
The IMS instrumentation is comprised of four major compo-
nents including: (A) ionization source; (B) ion gate; (C) drift
region; and (D) detector. Neutral molecules are introduced
into IMS and ionized with different procedures. Then, a
bundle of ions, known as a swarm, is introduced into a voltage
gradient or electric field (E, V/cm). The ion swarm attains an
average velocity through the electric field, called the drift
velocity (Vd, cm/second), at ambient pressure in a gas. Theic Azad University, Yazd, Iran.
ished by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license. 
Fig. 1 e Chemical structure of tramadol.
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where K is the mobility constant. In drift region, ions are
separated based on their mobility. As a result, diverse ions
reach the detector at different drift times, which are charac-
teristic of the ions considered. A mobility spectrum is a plot of
current or voltage signal versus drift time. The number of ions
reaching the detector is a measure of the analyte concentra-
tion. Portability, speed, sensitivity, and low cost are the main
advantages of IMS [12e14].
In this work, the IMS method was developed for the
determination of tramadol. Corona discharge in positivemode
is used for the ionization of the vaporized analyte molecules.
The operating instrumental conditions of IMS such as tem-
perature, voltage, and gas flow rate were investigated and
optimized. The analytical parameters of the proposedmethod
are comparable to those of other methods used for tramadol
determination. The biological applications of the IMS method
were evaluated by tramadol analysis in human plasma, saliva,
serum, and urine samples.2. Instrumentation and methods
2.1. Apparatus
The ion mobility spectrometer with a corona discharge ioni-
zation source was constructed at Isfahan University of Tech-
nology (IUT, Isfahan, Iran). Fig. 2 shows a schematic diagramFig. 2 e Schematic diagram of an ion mobility spectrometer (IMS
of Technology (IUT).of the spectrometer [15,16]. The main parts of instrument are:
the IMS cell, the needle for producing the corona, two power
supplies, a pulse generator, an analog to digital converter, and
a computer. The IMS cell, including the ionization and drift
regions, was inserted in an oven. The ionization region and
drift tube consisted of 16 aluminum rings which were isolated
from each other by thin Teflon insulators. The rings were
connected using a series of resistors to make a potential
gradient. The instrument was also equipped with a needle-to-
plane corona discharge ionization source in positive and
negative modes. A shutter grid was applied to produce an ion
pulse to the drift region by the pulse generator. To display the
ion mobility spectrum, an analog to digital converter (Pico-
Scope, UK) was used. The total peak area of product ions over
the acquisition time (from time of appearance until the
disappearance of analyte peak; average time: 60 seconds and
themaximal amplitude: 1mv)was obtained using a laboratory
made integrator program. The total peak area was considered
as the IMS signal. The obtained peak information was further
processed and analyzed with Microsoft Excel. The results are
the averages of three experiments in each concentration.
2.2. Chemical and reagents
Tramadol hydrochloride (purity >99%) was obtained from
Arya Co. (Tehran, Iran). A stock standard solution of tramadol
hydrochloride (100 mg/mL) was prepared in distilled water.
Blank human plasma, saliva, serum, and urine samples were
obtained from healthy volunteers (n ¼ 3, age ¼ 20e25 years,
male and female, nonsmokers; taken from the Shahvali Hos-
pital of IAU-Yazd, Iran). C18 cartridge columns (Supelco Inc.,
100mg)were supplied fromSigma-Aldrich (St. Louis,Mo,USA).
Ammoniumbicarbonate, ethyl acetate,methanol, and sodium
hydroxidewere purchased fromMerck (Darmstadt, Germany).
2.3. The extraction procedures of tramadol from
different biological samples
The known amounts of tramadol were spiked to blank tissue
of different biological samples (plasma, saliva, serum, and
urine) and then, a liquideliquid extraction or solid-phase
extraction procedure (described below) was used for sample
preparation [17,18].
Human plasma (1.0 mL) was placed into a glass tube con-
taining 0.1 mL of NaOH (2.0 M) and mixed for 10 seconds, and). Reprinted with kind permission from Isfahan University
Table 1 e The operating instrumental conditions of ion
mobility spectrometry (IMS).
Parameter Setting
Corona voltage (kV) 2.3
Drift voltage (kV) 7.0
Flow rate of drift gas (N2, mL/min) 600
Flow rate of carrier gas (N2, mL/min) 300
Injection port temperature (C) 220
IMS cell temperature (C) 190
Pulse width (ms) 100
Fig. 3 e Ion mobility spectra of tramadol and background.
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minutes), it was centrifuged at 10,000 rpm for 5 minutes and
then 1.0 mL of the supernatant solution was injected into IMS.
To apply the extraction of saliva, samples were first diluted
twice with distilled water and then extracted (similar to
plasma) and injected into IMS.
For sample preparation of human serum, 1.0 mL was
placed into a glass tube and then 3.0 mL of methanol was
added,mixed for 20 seconds, and centrifuged at 10,000 rpm for
10 minutes. A volume of 1.0 mL of the methanol layer was
transferred to a clean glass tube and 2.0 mL of methanol was
added and centrifuged again at 10,000 rpm for 5 minutes.Table 2 e Comparison of analytical parameters of the propose
tramadol at different samples.
Method Sample LDR (ng/mL) LOD (ng/mL)
HPLC-UV Plasma 12.5e800 9.0
HPLC-FL Saliva 100e6000 e
GC-MS Oral fluid 10e100 e
GC-MS Hair 0.5e5.0 0.5
HPLC-FL Urine (2e100)  103 e
HPLC-MS/MS Urine (dog) 1e1000 5.0
IMS Plasma 0.5e37.5 0.1
Saliva 0.8e35.0 0.2
Serum 0.5e40.0 0.3
Urine 0.5e45.0 0.1
FL ¼ fluorescence; GC ¼ gas chromatography; HPLC ¼ high performance li
dynamic range; LOD ¼ limit of detection; LOQ ¼ limit of quantitation; MSThen, 1.0 mL of the supernatant solution was loaded on a C18
cartridge column that had been pretreated with 1.0 mL of
methanol, 1.0 mL of water, and 2.0 mL of ammonium car-
bonate buffer (0.01M, pH¼ 9.3). After loading, the C18 cartridge
was washed with 1.0 mL of distilled water and 2.0 mL of
ammonium carbonate buffer (0.01 M, pH ¼ 9.3) and then tra-
madol eluted with 1.0 mL of methanol. Finally, 1.0 mL of this
solution was introduced into the injection port of the IMS.
For urine samples, 5 mL of it was first diluted with 5 mL of
distilled water and then centrifuged at 14,000 rpm for 5 mi-
nutes. A volume of 1.5 mL of solution was transferred to a
glass tube and 2.0 mL of ammonium carbonate buffer (0.01 M,
pH¼ 9.3) was added and centrifuged again at 14,000 rpm for 10
minutes; it was then applied to the C18 cartridge column
(similar to the serum sample). Finally, 1.0 mL of the methanol
solution was injected into the IMS.
2.4. Method validation
Method validation was performed based on the international
conference on harmonisation (ICH)-guideline [19]. The cali-
bration curves (linear dynamic ranges, LDRs) for tramadol in
different biological samples were obtained by least squares
linear regression. These were constructed using the several
spiking levels within 0.5e45 ng/mL of tramadol in the blank
tissue (drug free) from plasma, saliva, serum, and urine
samples. Precision of the developed method was determined
by repeatability and expressed as the relative standard devi-
ation (RSD%). The formula of RSD% is: (standard deviation/
average concentration) 100. The accuracy of themethodwas
reported as recovery by comparing the concentrations at three
levels calculated from the calibration curve to their spiked
concentrations. The limit of detection (LOD) and limit of
quantitation (LOQ) were calculated using 3sb/m and 10sb/m,
respectively, where sb is the standard deviation of the signal
intensity for the blank sample and m is the slope of the cali-
bration curve.3. Results and discussion
Chromatographic techniques, especially HPLC, were consid-
ered as the first choice for tramadol analysis. However, thesed method with other methods in the determination of
LOQ (ng/mL) RSD (%) Recovery (%) Ref.
e 1.2 88.5 [20]
2.5 3.3 97.3 [17]
10 2.4 87.7 [13]
e 6.7 90.7 [21]
2.5  103 10.6 97.1 [17]
10.0 2.7 82.0 [22]
0.4 8.1 98.7e100.7 This work
0.6 7.8 97.4e100.8
1.0 8.8 90.0e99.4
0.3 7.5 99.3e103.9
quid chromatography; IMS ¼ ion mobility spectrometry; LDR ¼ linear
¼ mass spectrometry; RSD ¼ relative standard deviation.
Fig. 6 e Calibration curve for tramadol extracted from
spiked serum samples.
Fig. 4 e Calibration curve for tramadol extracted from
spiked plasma samples.
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equipment and are solvent-consuming. In order to fulfill the
growing needs for determining and control of tramadol, a
simple and rapid IMS method was developed with the po-
tential for use for the analysis of the drug in different biolog-
ical samples.
3.1. Optimization of the operating instrumental
conditions of IMS
The ion mobility spectra of tramadol and background are
shown in Fig. 3. The analyte spectrum shows only one peak at
about 10 milliseconds. In order to obtain the best sensitivity,
the effective instrumental parameters including corona and
drift voltages, injector port and cell temperatures, carrier and
drift gas flow rates, and pulse width were investigated and
optimized; the results are presented in Table 1. Among these,
temperature (injection and oven) is an important parameter.
The effect of the injection temperature on the signal intensity
was studied in the range 180e230C with the IMS cell tem-
perature (oven) 180C. The signal intensity increases until
220C and remains constant at higher temperatures. There-
fore, 220C was selected for future study. Similarly, the effect
of the IMS cell temperature on signal intensity was studied inFig. 5 e Calibration curve for tramadol extracted from
spiked saliva samples.the range 150e200C, with the injection port temperature
220C. The results show that the signal intensity improves
with increase in the IMS cell temperature up to 190C and then
it does not change. Therefore, 190C was selected as the op-
timum value of the IMS cell temperature.3.2. Analytical parameters
The analytical parameters of the IMS method for the deter-
mination of tramadol are given in Table 2 [13, 17, 20e22].
Under the optimized conditions (Table 1), calibration curves
(LDRs) were found to be linear within 0.5e45 ng/mL, with the
correlation coefficients close to one; R2  0.998 (Figs. 4e7). The
concentrations were at the concentration level for the deter-
mination of tramadol in the tested real samples. At higher
concentrations, saturation of the signal generated of the an-
alyte occurred and the linearity of the calibration curves was
destroyed; this status must be avoided. The ion mobility
spectra of the extracted tramadol of different biological sam-
ples show that the position and shape analyte peaks are
similar to Fig. 3. This means that the extraction procedures
could provide clean extracts in which no extra peaks were
observed in the region where the analyte appeared. The dif-
ference in the region of reactant ions can be concerned to theFig. 7 e Calibration curve for tramadol extracted from
spiked urine samples.
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measurements were found to be lower than 9%. LOD and LOQ
values were 0.1e0.3 ng/mL and 0.3e1 ng/mL, respectively.
Analytical parameters of the proposed IMS are comparable
with other methods reported in previous studies (Table 2).
According to the results, the LODs and LOQs of the proposed
method are better than those of other methods. This shows
that IMS can determine trace levels of tramadol in biological
samples. The LDRs and recovery data also are comparable
with those reported in literature. Furthermore, the proposed
method is simple, rapid, and does not need expensive equip-
ment and hazardous solvents.
3.3. Biological applications of proposed method
Plasma, saliva, serum, and urine samples were analyzed to
demonstrate the capability of the proposed method in deter-
mining tramadol in real samples. In this regard, spiked bio-
logical samples were prepared at three concentrations (2, 15,
and 30 ng/mL) by addition of the standard solution of trama-
dol to blank samples. Then, tramadol was extracted according
to the procedures described in the experimental section and
injected into the IMS. The recoveries obtained (Table 2)
demonstrate the capability of the developed method in the
quantitative detection of tramadol in biological samples.
In humans, tramadol is metabolized to its metabolites.
With regard to the chemical structure of these compounds, we
expect that the product ions of them could be also created in
the IMS. By contrast, real samples could include some other
drugs, which may result in creating peaks which interfere
with that of tramadol. Therefore, a preseparation technique
may be required for quantitative analysis of real samples
before the analyte is introduced into IMS.Conflicts of interest
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